The Effect of Exercise on Preventing Depression in Young People

March 24, 2022 updated by: Kangguang Lin, Guangzhou Psychiatric Hospital

A Multi-center, 12-month,Parallel-group, Randomised Controlled Exercise Trial in Young People With Subthreshold Depression

It is estimated that approximately 30% of child and adolescents manifest subthreshold depression, which can further develop into major depression with as high as 25%-50% within one year. The main aim of this trial is to investigate the effect of long-term exercise on preventing major depression and depressive symptoms in young people (aged 10-17 years old). Other aims include the underlying mechanisms of how aerobic exercise works and predictors for treatment response.

Study Overview

Detailed Description

This is multi-center, psycho-education randomized controlled trial, consisting of two periods with each of 6 months (i.e supervised and maintenance period). In the exercise intervention arm, during the first 6 months, participants will be asked to do moderate-intensity aerobic exercise 3-4 times a week, which will be supervised in person by physical educators/professionals. In the next 6-month maintenance period, participants will be asked to continue doing aerobic exercise at the same intensity and frequency, which will not be supervised in person by educators/professionals, but they will be sent reminders and report adherence weekly. All of the physical activity will be recorded by accelerometer at scheduled time points (e.g. the first week, 6 week, 3 month, 6 month, 9 month, 12 month). Psycho-education group will be given 6 sections of general psycho-education onsite and/or virtually dependent on the surroundings with regards to the impact of the COVID-19 pandemic. The main aim of this trial is to investigate the effect of long-term aerobic exercise on prevention depression in young people with subthreshold depression.

Study Type

Interventional

Enrollment (Anticipated)

370

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Shaoxing, Guangdong, China
        • Recruiting
        • The first Huaiji middle school
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • There are two or more Diagnostic and Statistical Manual of Mental Disorder (DSM)-5 depressive symptoms, including at least one core symptom.
  • Any of the core symptoms of subclinical depressive syndrome lasts at least one week, with symptom manifestation ≥50% of the time.
  • CES-DC ≥16 points, Altman Self-Rated Mania Scale (ASRM) < 13 points.
  • 10~17 years old.

Exclusion Criteria:

  • Current or past DSM-5 criteria for major depressive disorder,Bipolar disorder, Schizophrenia.
  • With moderate or above suicide risk determined by Columbia-Suicide Severity Rating Scale (C-SSRS) (who will be referred to psychologist and/or psychiatrist for follow-up intervention)
  • Musculoskeletal problems such as arthritis, gout, osteoporosis, or back, hip or knee pain that may interfere with exercising
  • A history of organic brain disease or brain trauma
  • Alcohol, drug or other psychoactive substance abuse or dependence
  • Currently enrolled in another exercise study
  • Any condition that would make exercise unsafe or unwise
  • Taking medication that interferes with heart rate response to exercise such as beta blockers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic Exercise
The whole exercise lasts for 12 months, consisted of 6-month supervised exercise and 6-month maintenance period. It is moderate -intensity exercise (60-80% Maximum heart rate), each time last for 30 mins (plus 10-minutes for warm-up and cool-down), 3-4 times a week, for the first six months, which will be supervised in person by physical educators and/or physical professionals. In the maintenance period, participants are asked to exercise at the same intensity and frequency, but will not be supervised in person by physical educators/professionals. They will receive reminder on a weekly basis and their physical activities be recorded by accelerometer. Types of exercise will be chosen according to individual school's facility and feasibility, including jogging, fast walking, badminton, running, football etc.
The whole exercise lasts for 12 months, consisted of 6-month supervised exercise and 6-month maintenance period. It is moderate -intensity exercise (60-80% Maximum heart rate), each time last for 30 mins (plus 10-minutes for warm-up and cool-down), 3-4 times a week, for the first six months, which will be supervised in person by physical educators and/or physical professionals. In the maintenance period, participants are asked to exercise at the same intensity and frequency, but will not be supervised in person by physical educators/professionals. They will receive reminder on a weekly basis and their physical activities be recorded by accelerometer. Types of exercise will be chosen according to individual school's facility and feasibility, including jogging, fast walking, badminton, running, football etc.
Placebo Comparator: Psycho-education
It consists of 6 sections of psycho-education, with topics covering mood regulations and mental well-being. Approximately 1 section in every two months.
It consists of 6 sections of psycho-education, with topics covering mood regulations and mental well-being. Approximately 1 section in every two months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Onset of Major depressive Disorder (MDD)
Time Frame: month 6 and month 12
Kiddie-Sads-Present and Lifetime Version (K-SADS-PL)
month 6 and month 12
Changes from baseline in CES-DC at month 6
Time Frame: month 6 and month 12
Center for Epidemiological Studies Depression Scale for Children (CES-DC) is a self rating scale and has been shown to be effective in groups aged 6-23. CES-DC is used to measure the depressive severity;its measured time range is within the past week. In this study, version of 20-items is used. The higher the score indicates the more severe the depression symptoms, the scale author recommends 15 points as the screening demarcation value.
month 6 and month 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cognitive function from baseline
Time Frame: Month 3,6 and month 12
Cognitive function is measured by THINC-it tool, a tool for cognitive assessment.
Month 3,6 and month 12
Levels of inflammatory biomarkers from baseline
Time Frame: Month 3, 6 and month 12
inflammatory biomarkers (IL-6, CRP etc) will be analyzed using ELISA
Month 3, 6 and month 12
Brain structural and functional changes over time
Time Frame: month 3,6, or 12
Multimodal 3T MRI will be used
month 3,6, or 12
Occurrence of Non-suicidal self-injury and suicidal behavior
Time Frame: Month 6 and month 12
Month 6 and month 12
Physical activity level
Time Frame: Month 6, 9 and 12
The International Physical Activity Questionnaire - Short Form (IPAQ - SF) will be used to assess physical activity level
Month 6, 9 and 12
Electroencephalograph (EEG) scalp signal changes over time
Time Frame: Month 3, 6 and 12
Brain activity will be measured by the EEG
Month 3, 6 and 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kangguang Lin, MD,PhD, The Affiliated Brain Hospital of Guangzhou Medical University
  • Principal Investigator: Tifei Yuan, PhD, Shanghai Mental Health Center
  • Study Chair: Kwok-Fai So, PhD, Jinan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2021

Primary Completion (Anticipated)

May 20, 2023

Study Completion (Anticipated)

December 6, 2023

Study Registration Dates

First Submitted

March 23, 2021

First Submitted That Met QC Criteria

March 23, 2021

First Posted (Actual)

March 25, 2021

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

March 24, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Aerobic exercise intervention

3
Subscribe